Michael E. Faerm - 14 May 2024 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Reporting relationship: Chief Financial Officer
Issuer ticker: VIRX
Reported as of: 14 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2024, 16:26:48 UTC
Prior SEC filing: 16 May 2024
Next SEC filing: 13 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael E. Faerm

Key filing fact

Michael E. Faerm filed Form 4 for Viracta Therapeutics, Inc. (VIRX) on 16 May 2024.

Key facts

This page summarizes Michael E. Faerm's Form 4 filing for Viracta Therapeutics, Inc. (VIRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 May 2024, 16:26.

Change

Previous filing in this sequence was filed on 16 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 14 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.8040
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is May 13, 2024.